From prompt to patent: The legal challenge of AI-designed drugs
Louise Martin discusses the integration of AI into drug discovery and the legalities of patenting AI-designed drugs.
drug discovery
Continue reading
Machine learning improves the discovery of “silver shotgun” drugs
Aishwarya Vedula discusses the development of a novel machine learning approach that could revolutionise phenotypic drug discovery.
IP landmark cases: the basics
Emanuel Bor kicks off the new IP landmark cases series by explaining what a patent is and the process needed to obtain one.
Lecanemab: A new drug with potential to slow Alzheimer’s
Corenna Twiss reports on the development of lecanemab, a new monoclonal antibody drug which may be able to treat Alzheimer’s.
